// App-Quantinova.ai

611 : Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Researchers

Presenter

  • Marco Mielcarek

Principal Investigators

  • Terry Furlong

  • Paul V. -Donnell

  • Barry E. Storer

  • Jeannine S. McCune

  • Rainer F. Storb

  • Paul A. Carpenter

  • Mary E. D. Flowers

  • Frederick R. Appelbaum

  • Paul J Martin

Medical Centers

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Dept of Medicine, Univ of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine eent

  • fludarabine tablet

  • Busulfan

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved